alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 80, Number 5 (Thursday, January 8, 2015)]
[Notices]
[Page 1032]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-00040]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review: Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Member Conflict: Aspects of NeuroAIDS.
    Date: January 9, 2015.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mary Clare Walker, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5208, MSC 7852, Bethesda, MD 
20892, (301) 435-1165, <a href="/cdn-cgi/l/email-protection#6017010c0b05120d03200313124e0e09084e070f16"><span class="__cf_email__" data-cfemail="c6b1a7aaada3b4aba586a5b5b4e8a8afaee8a1a9b0">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

     Dated: December 31, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-00040 Filed 1-7-15; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<PAGE>

                                                                    Exhibit 23.3

                       CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the use in this Amendment No. 2 to the Registration
Statement on Form F-4 of Millar Western Forest Products Ltd. of our report dated
February 20, 2004 relating to the financial statements of Millar Western Forest
Products Ltd. as at December 31, 2003 and 2002 and for each of the years in the
three-year period ended December 31, 2003, which appear in such Registration
Statement. We also consent to the reference to us under the heading "Experts" in
such Registration Statement.


/s/ PricewaterhouseCoopers LLP


Edmonton, Canada
May 13, 2004
<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars
       
<S>                            <C>
<PERIOD-TYPE>                  6-MOS
<FISCAL-YEAR-END>              DEC-31-1997
<PERIOD-START>                 JAN-01-1997
<PERIOD-END>                   JUN-30-1997
<EXCHANGE-RATE>                       1
<CASH>                                0
<SECURITIES>                          0
<RECEIVABLES>                         0
<ALLOWANCES>                          0
<INVENTORY>                           0
<CURRENT-ASSETS>                      0
<PP&E>                                0
<DEPRECIATION>                        0
<TOTAL-ASSETS>                    3,320
<CURRENT-LIABILITIES>           201,704
<BONDS>                               0
<PREFERRED-MANDATORY>                 0
<PREFERRED>                           0
<COMMON>                          1,930
<OTHER-SE>                     (196,454)
<TOTAL-LIABILITY-AND-EQUITY>      3,320
<SALES>                               0
<TOTAL-REVENUES>                      0
<CGS>                                 0
<TOTAL-COSTS>                         0
<OTHER-EXPENSES>                 21,507
<LOSS-PROVISION>                      0
<INTEREST-EXPENSE>                    0
<INCOME-PRETAX>                 (21,507)
<INCOME-TAX>                          0
<INCOME-CONTINUING>             (21,507)
<DISCONTINUED>                        0
<EXTRAORDINARY>                       0
<CHANGES>                             0
<NET-INCOME>                    (21,507)
<EPS-PRIMARY>                      (.11)
<EPS-DILUTED>                      (.11)
        

</TABLE>
Exhibit 4.13


Exhibit 4.13


THIRD AMENDMENT
TO THE
CARDINAL HEALTH 401(K) SAVINGS PLAN
(As amended and restated January 1, 2011)


Background Information


		
	A.
	Cardinal Health, Inc. (“Cardinal Health”) previously adopted and currently maintains the Cardinal Health 401(k) Savings Plan (the “Plan”) for the benefit of employees of Cardinal Health and its subsidiaries and affiliates.




		
	B.
	Section 12.02 of the Plan permits the amendment of the Plan at any time.




		
	C.
	The Cardinal Health, Inc. Financial Benefit Plans Committee (the “Committee”) is authorized to make certain amendments to the employee benefits plans maintained by Cardinal Health and the subsidiaries and affiliates of Cardinal Health, Inc., including the Plan, and is authorized to approve amendments required by the Internal Revenue Service in connection with a determination letter application in accordance with the authority delegated by the Human Resources and Compensation Committee of the Board of Directors of Cardinal Health.




		
	D.
	The Committee desires to amend the Plan to reflect and clarify the qualification requirements for Cardinal Health common shares to be offered as an investment option under the Plan, as requested by the Internal Revenue Service.




Amendment of the Cardinal Health 401(k) Savings Plan


The Plan is hereby amended as set forth below, retroactively effective as of January 1, 2011.


		
	1.
	Section 1.40 of the Plan, “Shares,” is hereby amended to read as follows:




“Shares.  The no par value common shares of Cardinal Health, Inc., an Ohio corporation, which are publicly traded on the New York Stock Exchange under ticker symbol CAH.”  


		
	2.
	All other provisions of the Plan shall remain in full force and effect.


	
			
	 
	CARDINAL HEALTH, INC.

	 
	By:
	/s/ Kendell F. Sherrer

	 
	Its:
	V.P., Benefits

	 
	Date:
	6-12-14




		
	3.
EX-35.1
(logo) CAPMARK

Annual Statement as to Compliance
For the Year Ended December 31, 2007


J.P. MORGAN CHASE COMMERCIAL MORTGAGE SECURITIES CORP.
Series 2007-CIBC18


Pursuant to Section 11.09 of the Pooling and Servicing Agreement governing the
referenced transaction, I hereby attest that:

i. A review of the activities of Capmark Finance Inc. as Master Servicer during
the period, and of its performance under this Pooling and Servicing Agreement,
has been made under my supervision.

ii. To the best of my knowledge, based on such review, Capmark Finance Inc. as
Master Servicer, has fulfilled in all material respects its obligations under
this Pooling and Servicing Agreement throughout the period.


Capmark Finance Inc.


/s/ Mark E. McCool

By: Mark E. McCool
Title: Managing Director
Date: February 20, 2008



Real Estate Finance, Investments, Services

Capmark Finance Inc.
116 Welsh Road
Horsham, Pa 19044
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JANUARY 5, 2017

NO. 03-16-00761-CV

John S. Stritzinger, Appellant

v.

Christiana Trust, A Division of Wilmington Savings Fund Society, FSB, Appellee

APPEAL FROM THE 126TH DISTRICT COURT OF TRAVIS COUNTY

BEFORE JUSTICES PURYEAR, PEMBERTON, AND FIELD

DISMISSED -- OPINION BY JUSTICE FIELD

This is an appeal from the judgment signed by the trial court on September 14, 2016. Having 

reviewed the record, the Court finds that the appeal should be dismissed. Therefore, the Court 

dismisses the appeal. No costs of appeal shall be assessed in this Court or in the court below.
I 

118TH CONGRESS 

1ST SESSION H. R. 2502 

To repeal the Gun-Free School Zones Act of 1990 and amendments to 

that Act. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 6, 2023 

Mr. MASSIE (for himself, Mr. BIGGS, Mrs. BOEBERT, Mr. BRECHEEN, Mr. 

BURLISON, Mr. CLYDE, Mr. DAVIDSON, Mr. DUNCAN, Mr. GAETZ, Mr. 

GOOD of Virginia, Mr. GOSAR, Ms. GREENE of Georgia, Ms. HAGEMAN, 

Mr. LAMALFA, Mrs. LUNA, Mr. MCCLINTOCK, Mrs. MILLER of Illinois, 

Mr. MOONEY, Mr. MOORE of Alabama, Mr. PERRY, Mr. 

RESCHENTHALER, Mr. ROY, and Mr. ROSENDALE) introduced the following bill; which was referred to the Committee on the Judiciary 

A BILL 

To repeal the Gun-Free School Zones Act of 1990 and 

amendments to that Act. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Safe Students Act’’. 

5 SEC. 2. REPEAL OF THE GUN-FREE SCHOOL ZONES ACT OF 

6 1990 AND AMENDMENTS TO THAT ACT. 

7 (a) IN GENERAL.—Section 922 of title 18, United 

8 States Code, is amended by striking subsection (q). 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 2502 IH

1 (b) RELATED AMENDMENTS.— 

2 (1) Section 921(a) of such title is amended by 

3 striking paragraphs (25) through (27) and redesig4 nating paragraphs (28), (29), and (32) through (37) 

5 as paragraphs (25) through (32), respectively. 

6 (2) Section 924(a) of such title is amended— 

7 (A) in paragraph (1)(B), by striking ‘‘(k), 

8 or (q)’’ and inserting ‘‘or (k)’’; and 

9 (B) by striking paragraph (4) and redesig10 nating paragraphs (5) through (8) as para11 graphs (4) through (7), respectively. 

12 (3) The Gun-Free School Zones Act of 1990 

13 (18 U.S.C. 921 note, 922 note; section 1702 of Pub14 lic Law 101–647; 104 Stat. 4844–4845) is repealed. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
<PAGE>

                 MICRO BIO-MEDICS, INC. AND SUBSIDIARIES
                                FORM 10-Q
                            FEBRUARY 28, 1997
                               (UNAUDITED)
                 _______________________________________
Exhibit 11
__________


     Computation of Earnings per Common and Common Equivalent Share
     ______________________________________________________________

                                               Three Months Ended
                                            __________________________
                                            February 28,  February 29,
                                                1997          1996
                                            ____________  ____________

Earnings
________

Net income                                   $  218,536   $   87,916

Modified Treasury Stock Method
______________________________

Incremental income                                            44,930
                                             ___________  ___________
Adjusted income                              $  218,536   $  132,846
                                             ===========  ===========
Shares
______

Weighted average number of
  common shares outstanding                   5,065,065    4,020,182
Additional shares assuming conversion of:
  Stock options and warrants utilizing the
  modified treasury stock method              1,084,278    1,478,842
                                              __________  ___________
Number of common and common
  equivalent shares                           6,149,343    5,499,024
                                              ==========  ===========
Earnings per common and common
  equivalent share                              $.04         $.02    
                                               =========   ==========
Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as chief executive officer of Charlotte Russe Holding, Inc. (the Company), does hereby certify that to the undersigneds knowledge:

1) the Companys annual report on Form 10-K for the year ended September 29, 2007 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2) the information
contained in the Companys annual report on Form 10-K for the year ended September 29, 2007 fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/    MARK A.
HOFFMANMark A. Hoffman Chief Executive Officer (Principal Executive Officer)


Date: November 26, 2007

A signed original of this written statement required by Section 906 has been provided to Charlotte Russe Holding, Inc. and will be retained by Charlotte Russe Holding, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.
Exhibit 32.2
 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
 In connection with the Annual Report on Form 10-K of HeartWare International, Inc. (the
Company) for the fiscal year ended December 31, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the Report), the undersigned Chief Financial Officer of the
Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that based on his knowledge:
 (1)
    
    the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
 (2)
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 Date: February 24, 2011
 /s/ David McIntyreDavid McIntyreChief Financial Officer
(Principal Financial Officer)
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 95-6722

GUYN RALPH MCGEE,

Plaintiff - Appellant,

versus

GARY WATERS, Sheriff; DOCTOR PENALOSA; J.

SMITH, Classification; PORTSMOUTH CITY JAIL,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. David G. Lowe, Magistrate Judge.

(CA-94-19-3)

Submitted: December 12, 1995 Decided: February 9, 1996

Before HALL and MICHAEL, Circuit Judges, and PHILLIPS, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Guyn Ralph McGee, Appellant Pro Se. John Dinshaw McIntyre, WILLCOX

& SAVAGE, Norfolk, Virginia; Carolyn Porter Oast, Teresa Rejent

Warner, John Anders Heilig, Robert Moreland, HEILIG, MCKENRY, FRAIM

& LOLLAR, Norfolk, Virginia, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
* The parties consented to trial by a magistrate judge. See 28

U.S.C.A. § 636(c) (West 1993).

2

PER CURIAM:

Appellant appeals from the district court's* order denying relief on his 42 U.S.C. § 1983 (1988) complaint. We have reviewed the

record and the district court's opinion granting partial summary

judgment and find no reversible error. Accordingly, we affirm the

court's final judgment order. McGee v. Waters, No. CA-94-19-3 (E.D.

Va. Apr. 26, 1995). We dispense with oral argument because the

facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional

process.

AFFIRMED
**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTINGFIRM**

          Weconsent to the incorporation by reference in Registration Statement No.333-164726 on Form S-8 of our report dated September 10, 2010 relating tothe consolidated financial statements of ShoreTel, Inc. and subsidiaries (the“Company”) (which report expresses an unqualified opinion), and our reportdated September 10, 2010 relating to the effectiveness of ShoreTel, Inc.’sinternal control over financial reporting, appearing in the Annual Report onForm 10-K of ShoreTel, Inc. for the year ended June 30, 2010. 

/s/ DELOITTE & TOUCHELLP

San Jose, California
I 

118TH CONGRESS 

1ST SESSION H. R. 1924 

To provide for a limitation on availability of funds for Department of Labor, 

Employment and Training Administration, Migrant and Seasonal Farmworker Programs for fiscal year 2024. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 29, 2023 

Mr. BIGGS (for himself, Mr. ROSENDALE, Mr. GAETZ, Mr. GOOD of Virginia, 

Mr. ROY, and Mr. CRANE) introduced the following bill; which was referred to the Committee on Education and the Workforce 

A BILL 

To provide for a limitation on availability of funds for Department of Labor, Employment and Training Administration, Migrant and Seasonal Farmworker Programs for 

fiscal year 2024. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HR 1924 IH

1 SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR 

2 DEPARTMENT OF LABOR, EMPLOYMENT AND 

3 TRAINING ADMINISTRATION, MIGRANT AND 

4 SEASONAL FARMWORKER PROGRAMS FOR 

5 FISCAL YEAR 2024. 

6 Notwithstanding any other provision of the law, 

7 amounts authorized to be appropriated or otherwise avail8 able for Department of Labor, Employment and Training 

9 Administration, Migrant and Seasonal Farmworker Pro10 grams for fiscal year 2024 may not exceed $88,896,000. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB
exv10w2



 





Exhibit 10.2




AMENDMENT TO THE FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT




ADVANCIS PHARMACEUTICAL CORPORATION




     This Amendment to the Form of Non-Qualified Stock Option Agreement is provided by Advancis
Pharmaceutical Corporation, a Delaware corporation (the “Company”), to notify holders of stock
options granted under the Amended and Restated Advancis Pharmaceutical Corporation Stock Incentive
Plan (the “Amended Stock Incentive Plan”) that pursuant to Section 21 of the Form of Non-Qualified
Stock Option Agreement (the “Option Agreement”), the Company’s Board of Directors has amended the
Option Agreement as follows:



Section 3. Vesting




     (a) Vesting Schedule. The Options, and the underlying Option Shares, vest in accordance
with the vesting schedule set forth on the Stock Option Notice (the “Vesting Schedule”), so long as
the Participant is in the continuous employ of, or in a service relationship with, the Company from
the Grant Date through the applicable date upon which vesting is scheduled to occur, except as
specified in paragraph (b) of this Section 3. The extent to which the Options or Option Shares are
vested as of a particular vesting date specified in the Vesting Schedule is rounded down to the
nearest whole share. However, vesting is rounded up to the nearest whole share with respect to the
last vesting date reflected on the Vesting Schedule. No vesting will accrue to any Options after
the Participant ceases to be in either an employment or other service relationship with the
Company, except as specified in paragraph (b) of this Section 3. In determining the vested status
of the Options and Option Shares in circumstances where some but not all of the Options have been
exercised, vesting under the Vesting Schedule is attributed first to Option Shares that have been
purchased, in the order in which they were purchased, and second to Option Shares underlying
unexercised Options.



     (b) Vesting upon a Change in Control. Unless the Options have earlier terminated, the
unvested Options become fully vested upon a Change of Control.



     (c) Vesting upon Death or Disability. Unless the Options have earlier terminated, the
unvested Options become fully vested upon termination of the Participant’s employment or other
service relationship with the Company as a result of the Participant’s Total and Permanent
Disability or death.


All of the remaining terms of this agreement remain in full force and effect.



Capitalized terms used herein without definition shall have the respective meanings ascribed to
them in the Form of Non-Qualified Stock Option Agreement.




	 	 	 	 	 
	 	Advancis Pharmaceutical Corporation

 	 
	 	By:  	 	 
	 	 	Edward M. Rudnic, Ph.D. 	 
	 	 	President and Chief Executive Officer
EX-31 Rule 13a-14(d)/15d-14(d) Certification.


  I, Jenna L. Kemp, certify that:

  1.I have reviewed this report on Form 10-K and all reports on Form 10-D
    required to be filed in respect of the period covered by this report on Form
    10-K of Bear Stearns ARM Trust 2007-1 (the "Exchange Act periodic reports");

  2.Based on my knowledge, the Exchange Act periodic reports, taken as a whole,
    do not contain any untrue statement of a material fact or omit to state a
    material fact necessary to make the statements made, in light of the
    circumstances under which such statements were made, not misleading with
    respect to the period covered by this report;

  3.Based on my knowledge, all of the distribution, servicing and other
    information required to be provided under Form 10-D for the period covered
    by this report is included in the Exchange Act periodic reports;

  4.I am responsible for reviewing the activities performed by the servicers and
    based on my knowledge and the compliance reviews conducted in preparing the
    servicer compliance statements required in this report under Item 1123 of
    Regulation AB, and except as disclosed in the Exchange Act periodic reports,
    the servicers have fulfilled their obligations under the servicing
    agreements in all material respects; and

  5.All of the reports on assessment of compliance with servicing criteria for
    asset-backed securities and their related attestation reports on assessment
    of compliance with servicing criteria for asset-backed securities required
    to be included in this report in accordance with Item 1122 of Regulation AB
    and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to
    this report, except as otherwise disclosed in this report. Any material
    instances of noncompliance described in such reports have been disclosed in
    this report on Form 10-K.

    In giving the certifications above, I have reasonably relied on
    information provided to me by the following unaffiliated parties:
    Countrywide Home Loans Servicing LP as Servicer, Wells Fargo Bank, N.A.
    as Servicer and Wells Fargo Bank, N.A. as Securities Administrator.

    Dated:   March 31, 2008


    /s/ Jenna L. Kemp
    Signature

    Executive Vice President
    (senior officer in charge of the servicing function of the master
    servicer)
118TH CONGRESS 

1ST SESSION H. R. 23 

AN ACT 

To rescind certain balances made available to the Internal 

Revenue Service. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 23 EH

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Family and Small 

3 Business Taxpayer Protection Act’’. 

4 SEC. 2. RESCISSION OF CERTAIN BALANCES MADE AVAIL5 ABLE TO THE INTERNAL REVENUE SERVICE. 

6 The unobligated balances of amounts appropriated or 

7 otherwise made available for activities of the Internal Rev8 enue Service by paragraphs (1)(A)(ii), (1)(A)(iii), (1)(B), 

9 (2), (3), (4), and (5) of section 10301 of Public Law 117– 

10 169 (commonly known as the ‘‘Inflation Reduction Act of 

11 2022’’) as of the date of the enactment of this Act are 

12 rescinded. 

Passed the House of Representatives January 9, 

2023. 

Attest: 

Clerk. 

118TH CONGRESS 

1ST SESSION H. R. 23 

AN ACT 

To rescind certain balances made available to the 

Internal Revenue Service.